baber/WOPTO huggingface dataset:
Patent NZ-332334-A (NZ)
Title: Substituted benzylamines and their use for the treatment of depression and other neurologically related disorders
Inventor: LEYSEN DIRK CASIMIR MARIA
IPC: A61K31/00
Filed: 1997-04-15
Abstract: Benzylamine derivatives of formula (I) wherein: R1 and R2, which may be the same or different, are each selected from C6-12aryl, C2-14heteroaryl, C6-12arylC1-6alkyl, C2-14heteroarylC1-6alkyl (where the alkyl, aryl or heteroaryl moiety may be optionally substituted by one or more substituents selected from C1-6alkoxy, C1-6alkyl, C3-6cycloalkyl, C4-6cycloalkenyl, C6-12aryl, C2-14heteroaryl, halogen, amino, hydroxy, haloC1-6alkyl, nitro, C1-6alkylthio, sulphonamide, C1-6alkylsulphonyl, hydroxy-C1-6alkyl, C1-6alkoxycarbonyl, carboxyl, carboxyC1-6alkyl, carboxamide and C1-6alkylcarboxamide), hydrogen, C1-6alkyl, C3-6cycloalkyl, C4-6cycloalkenyl, C2-6alkenyl, C2-6alkynyl and C1-6alkoxyC1-6alkyl (where the alkyl, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, or alkoxyalkyl moieties may be optionally substituted by one or more substituents selected from amino, halogen, hydroxy, C1-6alkylcarboxamide, carboxamide, carboxy, C1-6alkoxycarbonyl, C1-6alkylcarboxy and carboxyC1-6alkyl) or one of R1 and R2 are as hereinbefore defined and one is hydroxy; R3 and R4, which may be the same or different, are each selected from C6-12aryl, C2-14heteroaryl, C6-12arylC1-6alkyl, C2-14heteroarylC1-6alkyl (where the alkyl, aryl or heteroaryl moiety may be optionally substituted by one or more substituents selected from C1-6alkoxy, C1-6alkyl, C3-6cycloalkyl, C4-6cycloalkenyl, C6-12aryl, C2-14heteroaryl, halogen, amino, hydroxy, haloC1-6alkyl, nitro, C1-6alkylthio, sulphonamide, C1-6alkylsulphonyl, hydroxyC1-6alkyl, C1-6alkoxycarbonyl, carboxyl, carboxyC1-6alkyl, C1-6alkylcarboxamide and carboxamide), hydrogen, C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkylC1-6alkyl, C4-6cycloalkenyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy-C1-6alkyl, haloC1-6alkyl, haloC2-6alkenyl, haloC2-6alkynyl, cyano, carboxyl, C1-6alkylcarboxy and carboxyC1-6alkyl (where the alkyl, cycloalkyl, cycloalkenyl, alkenyl, alkynyl, or alkoxyalkyl moieties may be optionally substituted by one or more substituents selected from amino, hydroxy, C1-6alkylcarboxamide, carboxamide, carboxy, C1-6alkoxycarbonyl, C1-6alkylcarboxy and carboxyC1-6alkyl); or one of R3 or R4 together with one of R1 or R2 and the N atom to which it is attached form a 5- or 6-membered heterocyclic ring. R5 represents one or more ring substituents selected from halogen, hydrogen C1-6alkyl and C1-6alkoxy; R6 represents a single ring substituent of formula (A) wherein the dotted line represents an optional bond; Y is oxygen or -NR8 (where R8 is hydrogen or C1-6alkyl) R7 represents one or more substituents selected from hydrogen, halogen, haloC1-6alkyl, C1-6alkyl and C1-6alkoxy; or a pharmaceutically acceptable salt or solvate thereof. Also disclosed is the use of compounds of formula I as a medicament for the treatment or prevention of depression or other neurologically related disorders.
Patent NZ-337011-A (NZ)
Title: 2-amino-substituted pyridines for use in the treatment of arteriosclerosis and hyperlipoproteinaemia
Inventor: SCHMECK CARSTEN
IPC: A61P9/10
Filed: 1998-01-23
Abstract: Disclosed are 2-Amino-subsituted pyridines of formula (I) and pharmacologically acceptable auxiliaries and their use as medicaments for the treatment of arteriosclerosis and hyperlipoproteinaemia.
Patent NZ-501466-A (NZ)
Title: Producing 3D perspective image from photograph or video image of 3D object.
Inventor: HOYDAL FINN
IPC: G06T7/40
Filed: 1998-05-06
Abstract: A method for image processing, especially for converting a two-dimensional image of a three-dimensional real subject into a three-dimensional representation of the same three-dimensional real subject, wherein the subject is composed of elements, each of which is represented by a pixel in the two-dimensional image. The image's colours are subjected to an analysis with regard to colour quality, and the individual colour points' orientation in space is localised by utilizing a colour temperature scale, a colour saturation scale and a contrast scale, with the result that each colour obtains its perspective place relative to the image's other colours.
Patent NZ-502690-A (NZ)
Title: Push-type information transmission method and transfer device thereof
Inventor: SEKIGUCHI KATSUMI
IPC: G08C17/00
Filed: 1999-08-27
Abstract: A push type information transmission method in a communication network includes information provider server device, a plurality of user terminals for receiving information provided by the server service and a transfer device for routing information transmission between the server device and the user terminal.  The transfer device comprises a step of receiving information mail supplied with a network address of a user terminal as a desired destination from the server device; a step of storing the information mail; a step of calling the user terminal whose network address has been designated and a step of transmitting the stored information mail in response to a request from the called user terminal.
Patent NZ-504786-A (NZ)
Title: Sustained release compositions for nasal administration of drugs for treating erectile disfunction and parkinson's disease
Inventor: ILLUM LISBETH
IPC: A61K47/48
Filed: 1998-11-27
Abstract: There is provided a composition for the nasal delivery of a drug suitable for the treatment of erectile dysfunction to a mammal wherein the composition is adapted to provide an initial rise in plasma level followed by a sustained plasma level of the drug.
Patent NZ-507930-A (NZ)
Title: Phthalazine derivatives as PDE 4 inhibitors for the treatment of respiratory diseases and allergic and inflammatory conditions
Inventor: NAPOLETANO MAURO
IPC: A61K31/502
Filed: 1999-07-16
Abstract: A class of phthalazine derivatives able to inhibit PDE 4 and TNF-alpha is described.  In particular compounds of the formula (I) wherein ------ is a single or double bond; B is NH, methylene, a C2-6 alkylene chain optionally branched and/or unsaturated and/or interrupted by a C5-7 cycloalkyl residue; A is phenyl or heterocycle optionally substituted by one or more substituent(s) or a COR4 group wherein R4 is hydroxy, C1-4 alkyl, amino optionally mono- or di-substituted by a C1-6-alkyl group or monohydroxylated; R represents two hydrogen atoms or a C=O group when ------ is a single bond or, when ------ is a double bond, is hydrogen, optionally substituted aryl or heterocycle, (C1-8)-alkyl, (C2-8)-alkenyl or (C2-8)-alkynyl optionally substituted by aryl or heterocycle; aryloxy, heterocyclyloxy, aryl-C1-4-alkoxy, heterocyclyl-C1-4-alkoxy, amino substituted by one or two C1-4-alkyl group(s), aryl-amino, heterocyclyl-amino, aryl-C1-4-alkyl-amino, heterocyclyl-C1-4-alkylamino; R1 is a C1-6-alkyl, aryl, aryl-C1-10-alkyl, C4-7-cycloalkyl group optionally containing an oxygen atom and/or substituted by a polar substituent; R2 is a C1-6 -alkyl, polyfluoroC1-6-alkyl group; R3 is absent when ------ is a double bond, or, when ------ is a single bond, is a) hydrogen; b) C1-6-alkyl optionally substituted by aryl, by heterocycle or by a COR5 group wherein R5 is hydroxy, C1-4-alkoxy or hydroxyamino; c) -COR6 wherein R6 is hydrogen, aryl, aryl-C1-6-alkyl, amino optionally alkylated or monohydroxylated, hydroxy, C1-4-alkoxy, carboxy, C1-4-alkoxycarbonyl, or C1-4-alkyl optionally substituted by heterocycle; d) C1-4-alkyl-sulfonyl; the N--O derivatives of the compounds of formula (I) and the pharmaceutically acceptable salts thereof are PDE 4 inhibitors.
Patent NZ-509296-A (NZ)
Title: Hydroxy pipecolate hydroxamic acid derivatives as MMP inhibitors
Inventor: MCCLURE KIM FRANCIS
IPC: C07D401/12
Filed: 1999-08-05
Abstract: A compound of formula (I) that is useful in the treatment of a condition selected from the group consisting of arthritis, cancer, and other diseases characterized by matrix metalloproteinase or mammalian reprolysin activity is disclosed, wherein R1, R2 R3, R4 R5, R6, R7, R8, R9 and Ar are as defined in the specification. In addition, the compounds of the present invention may be used in combination therapy with standard non-steroidal anti- inflammatory drugs (NSAID'S), COX-2 inhibitors and analgesics, and in combination with cytotoxic drugs such as adriamycin, daunomycin, cis-platinum, etoposide, taxol, taxotere and other alkaloids, such as vincristine, in the treatment of cancer.
Patent NZ-510559-A (NZ)
Title: Glycosylated interferon-beta fusion proteins that are as active as forms that are not fusion proteins
Inventor: WHITTY ADRIAN
IPC: C07K17/08
Filed: 1999-10-15
Abstract: Described is a polypeptide comprising an interferon â 1a fused via its C terminus to at least a portion of the Fc region of an immunoglobulin such as IgG. Also described is the use of the polypeptide in the treatment of inflammatory, autoimmune, angiogenic and timorous or viral diseases.
Patent NZ-511234-A (NZ)
Title: 3-azabicyclo[3.1.0.] hexane derivatives useful as opiate receptors ligands
Inventor: PETTMAN ALAN JOHN
IPC: C07D413/12
Filed: 1999-11-19
Abstract: A 3-azabicyclo[3.1.0]hexane derivative or a pharmaceutically or veterinarily acceptable derivative thereof has the formula (I) wherein: the "Ar" ring represents an optionally benzo-fused phenyl or 5- or 6-membered heteroaryl ring; R1 when taken alone is H, halogen, NO2, NH2, NY2WY1, Het1, AD, CO2R7, C(O)R8, C(=NOH)R8 or OE and R2 when taken alone is H or halogen or R1 and R2, when attached to adjacent carbon atoms, can be taken together with the carbon atoms to which they are attached, and may represent Het1a; A is optionally substituted alkylene, alkenylene or alkynylene, each of which is by one or more C1-4 alkyl, C1-4 alkoxy, halogen and/or OH, D is H, OH, CN, NR25R26, CONR25R26, NHR27, CO2R28, COR29, C(=NOH)R29 or AD is CN, NR25R26, CONR25R26; E is H, CONR32R33, CSNR32R33, COR34, CO2R34, COCH(R34a)NH2, R35, CH2CO2R35a, CHR35bCO2R35a, CH2OCO2R35c, CHR35dOCO2R35c, COC36=CR37NH2, COCHR36CHR37NH2 or PO(OR38)2; R3 is CN, halogen, OH, alkoxy, alkoxycarbonyl, alkanoyl, alkanoyloxy, cycloalkyl, cycloalkyloxy, cycloalkanoyl, aryloxy, heteroaryl, NR12R13, CONR12R13, NY2WY1, or optionally substituted alkyl, alkenyl or alkynyl; R4 is an optionally substituted alkyl, alkenyl or alkynyl , ach of which groups is linked to the N atom via a sp3 carbon; R5 and R8 when taken separately are each independently H or alkyl or together with the carbon atoms to which they are joined form a cycloalkyl ring; R6, R7, R9 and R10 when taken separately are H or R5 and R6 or R7 can be taken together with the carbon atoms, to which they are joined to form a cycloalkyl ring; X is halogen, alkyl, alkoxy, haloalkyl or haloalkoxy; m is 1 or 2; n is 0, 1 or 2; p is 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10; q is 0 or 1 and Y2, W, Y1, Het1, Het1a, R7, R8, R12, R13, R25 to R29, R32 to R38 are as defined in the specification. The compounds are useful as opiate binding agents useful in the treatment of opiate-mediated conditions.
Patent NZ-523025-A (NZ)
Title: Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
Inventor: MUTEL VINCENT
IPC: A61K31/506
Filed: 2001-06-22
Abstract: Derivatives of 1-sulfonyl-pyrrolidine of formula (I) that demonstrate affinity towards metabotropic glutamate receptors are disclosed, wherein R1, R2 and R3 are as defined in the specification. Medicaments containing these compounds and a process for their preparation also disclosed. The compounds possess affinity towards metabotropic glutamate receptors and are therefore useful in the treatment or prevention of acute and/or chronic neurological disorders.
Patent NZ-523400-A (NZ)
Title: Use of communication equipment and method for authenticating an item, unit and system for authenticating items, and authenticating device
Inventor: AMON MAURICE A
IPC: G07D7/00
Filed: 2001-06-22
Abstract: Use of a mobile communication device (1) selected from the group consisting of mobile phones, hand-held computers and electronic organizers, for authenticating a security marking on an item (I), wherein at least one element , selected from the group of data processing and storage devices, data transfer devices, user-interface, machine- interfaces, and battery, is functionally connectable with an authenticating device.
Patent NZ-524315-A (NZ)
Title: Adjustable profiling head for a wood cutting apparatus
Inventor: STAGER BRADLEY R
IPC: B27L11/00
Filed: 2003-02-19
Abstract: An  adjustable profiling head (10) for a wood  cutting apparatus, comprising:     a  first body portion (12a) for carrying a plurality  of first  knives  (11)  having  cutting  edges  (11a)  defining thereby a first cutting surface of revolution about an axis, said  first body portion (12a) being adapted to receive said first knives (11)by respective clamping mechanisms (30)  for removably clamping said first knives (11) thereto;     a  second body portion (12b) for carrying a plurality of second  knives  (12)  having cutting  edges  (13a)  defining thereby  a  second cutting surface of revolution about  said axis,  said  second  body  portion (12b)  being  adapted  to receive  said  second  knives (12)  by  respective  clamping mechanisms  (40) for removably clamping said  second  knives (12)  thereto,  wherein said first and second body  portions (12a,  12b)  are adapted so that the mean diameter  of  said first  cutting surface is greater than the mean diameter  of said  second  cutting surface, and wherein  said  first  and second  body portions (12a, 12b) are adapted to be removably mounted  axially adjacent one another so that the respective said cutting surfaces axially displaced with respect to  one another an adjustable amount.
Patent NZ-525846-A (NZ)
Title: Improvements in feeder bottles
Inventor: MCINTYRE ROBERT DYMOCK
IPC: A61J9/04
Filed: 2003-05-14
Abstract: A lid for a feeding bottle adapted for use with an animal feeding teat, said lid including a breather hole and a thin membrane releasably covering said breather hole.
Patent NZ-530696-A (NZ)
Title: Pancam nucleic acids and polypeptides
Inventor: SUN CHAO
Filed: 2002-06-24
Abstract: Disclosed is an isolated polynucleotide encoding a novel immunoglobulin superfamily member named PanCAM (also named GP354). PanCAM has a predicted single membrane spanning domain and five immunoglobulin (Ig) domains in the extracellular portion of the protein. The protein structure and tissue distribution of PanCAM indicate that it plays a role in cell-cell recognition, binding, signaling and adhesion events in the pancreas (especially the beta islets), the pituitary gland, and the central nervous system (CNS). Also disclosed are isolated PanCAM related polynucleotides and polypeptides, vectors, and host cells comprising any of the above, antibodies directed to PanCAM, cells which produce such antibodies, and related diagnostic and therapeutic methods.
Patent NZ-536758-A (NZ)
Title: Combination of a DPP IV inhibitor and a cardiovascular compound which is valsartan
Inventor: HOLMES DAVID GRENVILLE
IPC: A61P7/02
Filed: 2003-05-28
Abstract: A combination comprising a DPP-IV inhibitor which is (S)-1-{2-[5-cyanopyridin-2yl)amino]ethyl-aminoacetyl)-2-cyano-pyrrolidine or (S)-1-[(3-hydroxyl-1-adamantyl)amino]acetyl-2-cyano-pyrrolidine or a pharmaceutically acceptable salt thereof and a cardiovascular compound which is valsartan or a pharmaceutically acceptable salt thereof. Also disclosed is the use of the combination in the manufacture of a medicament for the prevention of, delay of, progression of, or treatment of a particular disease or condition.
Patent NZ-538659-A (NZ)
Title: Transmission scheme for multi-carrier MIMO systems
Inventor: AGRAWAL AVNEESH
IPC: H04B7/04
Filed: 2003-10-14
Abstract: A "power adaptive circular" (PAC) transmission scheme that can support both spatial multiplexing and transmit diversity for multi-carrier MIMO systems and has a number of desirable characteristics, including the ability to: transmit a variable number of symbol streams, provide transmit diversity for each transmitted symbol stream, support coded interference estimation technique at a receiver, and use power efficiently. In one method, at least one stream of symbols is received for transmission on a plurality of subbands and from a plurality of antennas. The at least one stream of symbols is multiplexed such that (1) the symbols in each stream are transmitted from the plurality of antennas (e.g., diagonally across the subbands and antennas) and (2) the at least one stream starts in the same subband. A stream of multiplexed symbols is formed for each antenna and further processed, and may be transmitted at full power available for the antenna.
Patent NZ-539551-A (NZ)
Title: Rodent trap with electrodes and a floor plate that rotates relative to the cover
Inventor: TREMAIN MURRAY CARL
Filed: 2005-08-20
Abstract: An animal trap which includes: a floor plate; at least three electrodes which are spaced from each other; a cover for the floor plate such that the floor plate and the cover together form an enclosure; means to attract an animal onto the floor plate; means to rotate the floor plate relative to the cover; means for sensing the presence of an animal within the enclosure and means for applying an electrical potential difference of sufficient strength to kill the animal.
Patent NZ-543556-A (NZ)
Title: Materials and methods for the production and purification of chlorofluorocarbons and hydrofluorocarbons
Inventor: IIKUBO YUICHI
IPC: B01J23/44
Filed: 2002-09-27
Abstract: Disclosed is a hydrogenation process for C3 halogenated compounds, comprising contacting a C3 halogenated compound with both a catalyst and a hydrogenating reagent, in the presence of water to form a hydrohalogenated compound, the water being present in an amount of at least about 0.04 percent by weight of the C3 halogenated compound.
Patent NZ-545090-A (NZ)
Title: Management control of assets via biometric capture sensor and encrypted authentication
Inventor: SMITH CRAIG GREGORY
IPC: G07C9/00
Filed: 2004-07-02
Abstract: A computerised identity matching management process and system for regulating the issue of, or the return of, secure assets that uses a biometric capture sensor and encrypted authentication is provided. The process comprises steps of : a) identifying an asset having a unique classification identifier; b) identifying an issuer of the asset and a receiver of the asset, each comprising the steps of: a management computer receiving a request, from capture apparatus waiting to commence a capture process of a biometric representative of the issuer of the asset or the receiver of the asset, to initiate the capture process; the management computer responding to the request by returning a message to the capture apparatus, where the message contains a unique code and receipt of the message containing the code at the capture apparatus causing initiation of the capture process; the capture apparatus encoding a captured biometric representative of the issuer of the asset or representative of the receiver of the asset with the code; the management computer, after returning the message, receiving the encoded captured biometric; and the management computer decoding the captured biometric and initiating a matching process to find a match for the decoded captured biometric against stored records and generating an identification code representative of the issuer of the asset or representative of the receiver of the asset when a match is found; retrieving a receiver's privilege to determine whether the receiver's privilege matches the asset classification identifier and, if a match is determined issuing the asset and recording information to form a use record relating to the issue of the asset.
Patent NZ-545204-A (NZ)
Title: A burner for a heater, where when filling tank with fuel, the combustion control means closes at least part of gas exchange opening of combustion chamber
Inventor: BACKES UWE
IPC: F23D5/12
Filed: 2004-10-25
Abstract: A burner for a heater for combustion of a hydrocarbon liquid is disclosed. The burner comprises a combustion chamber having a combustion zone 17 combusting the hydrocarbon liquid ('liquid'). At least one tank portion contains the hydrocarbon liquid. The tank portion 13, 15 positioned adjacent to the combustion zone, where it is arranged to feed the liquid into the combustion zone. A combustion control means 22 is positioned in the combustion zone for controlling gas exchange. A fuel inlet opening has a closure, the closure is arranged so that filling of the fuel into the or each tank portion is only possible of the combustion control means closes at least a portion of the gas exchange opening of the combustion chamber.
Patent NZ-562754-A (NZ)
Title: A support and rotatable holder assembly
Inventor: RUSSELL TREVOR
Filed: 2006-04-20
Abstract: An assembly is disclosed for attaching devices or accessories (Ì) to a helmet (not shown). Said assembly comprises a mounting component (4) having a coupling member (3) that is complementary engageable with a rotational insert (2). The mounting component (4) may be attached to the helmet (7) and the rotational insert (2) associated with the device or accessory (1) to be attached, or vice versa. The rotational insert (2) is able to be rotated relative to the mounting component (4) in a direction of rotation axis substantially normal to the direction of engagement of the rotational insert (2) with the coupling member (3) of the mounting component (4).
Patent NZ-569236-A (NZ)
Title: Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and their use
Inventor: LU LI-SHENG
IPC: A61P35/00
Filed: 2006-12-08
Abstract: An antibody that binds to human protein tyrosine kinase 7 (PTK7) and comprises the heavy chain CDR1, CDR2 and CDR3 regions having SEQ ID NOs: 12, 16, and 20 respectively and the light chain CDR1, CDR2 and CDR3 regions having SEQ ID NOs: 25, 31 and 37. The antibody can be used to treat pancreatic or breast cancer.
Patent NZ-570813-A (NZ)
Title: Process for the acid digestion of metal-containing compounds
Inventor: HEIDENFELDER THOMAS
IPC: C22B3/00
Filed: 2007-02-28
Abstract: Disclosed is a process for the acid digestion of metal-comprising compounds by leaching by means of an aqueous leachant, wherein the leachant comprises i) one or more alkanesulfonic acids with a propyl, ethyl or methyl moiety and sulphuric acid at a weight ratio of alkanesulfonic acid to sulfuric acid from 1 : 1000 to 1 : 1, and/or ii) a mixture of one or more salts of alkanesulfonic acids with a propyl, ethyl or methyl moiety and sulfuric acid at a weight ratio of salt of alkanesulfonic acid to sulfuric acid is from 1 : 9 to 1 :99. Also disclosed is said leachant used in the process.
Patent NZ-571740-A (NZ)
Title: Light emitting device for use in therapeutic and/or cosmetic treatment with diffusing member
Inventor: SAMUEL IFOR DAVID WILLIAM
IPC: A61N5/06
Filed: 2007-04-26
Abstract: An ambulatory device for use in therapeutic and/or cosmetic treatment is disclosed. The device comprises a plurality of light sources (52, 54, 58 and 56) and a diffusing member (48) for distributing light passing through the diffusing member (48) from the light sources ( 52, 54, 56 and 58) over an area to be treated so as to evenly illuminate and cause treatment of that area. The light sources (52, 54, 58 and 56) are only situated at or around the periphery of the diffusing member (48).
Patent NZ-575099-A (NZ)
Title: Modification of plant and seed development and plant responses to stresses and stimuli (4)
Inventor: SPANGENBERG GERMAN
IPC: C07K14/415
Filed: 2002-05-07
Abstract: Provided is a substantially purified or isolated nucleic acid or nucleic acid fragment encoding a dehydrin (DHN) polypeptide, or complementary to antisense to a sequence encoding a DHN polypeptide, and including a specified nucleotide sequence, complement or antisense sequence or functionally active fragments and variants having at least approximately 80% sequence identity to the relevant part of the sequences and having a size of at least 20 nucleotides. Further provided are corresponding expression vectors, polypeptides and genetically modified plants comprising the DNA or protein.